Work

Correction: Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells

Year: 2024

Type: erratum

Source: Oncotarget

DOI: 10.18632/oncotarget.28536

Authors: Yunfei Liao, Lulu Chen, Yong Feng, Jacson Shen, Yan Gao, Gregory Cote, Edwin Choy, David Harmon, Henry Mankin, Francis Hornicek, Zhenfeng Duan

Institutions: Harvard University, Massachusetts General Hospital, Wuhan Union Hospital, Huazhong University of Science and Technology

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4391544903

Cites:

Cited by: 1

Related to: 10